T1	Intervention 29 40	antibiotics
T2	Intervention 64 85	H. pylori eradication
T3	Intervention 104 123	Helicobacter pylori
T4	Intervention 230 265	undergo different treatment options
T5	Intervention 282 299	H. pylori therapy
T6	Intervention 377 388	antibiotics
T7	Intervention 437 487	H. pylori-positive patients were randomly assigned
T8	Intervention 512 528	7-day treatments
T9	Intervention 548 591	amoxicillin, clarithromycin and rabeprazole
T10	Intervention 643 668	anitidine bismuth citrate
T11	Intervention 611 637	tinidazole, clarithromycin
T12	Intervention 688 742	tinidazole, clarithromycin and rabeprazole Eradication
T13	Intervention 759 779	13C-Urea Breath Test
T14	Intervention 856 923	second cycle with tinidazole, tetracycline, bismuth and rabeprazole
T15	Intervention 820 834	Not-eradicated
T16	Intervention 963 1040	validated questionnaire regarding presence and intensity of drug side effects
T17	Intervention 1094 1121	H. pylori-positive patients
T18	Intervention 1176 1193	eradication rates
T19	Intervention 1238 1265	intention to treat analysis
T20	Intervention 1277 1294	protocol analysis
T21	Intervention 1535 1553	first-line therapy
T22	Intervention 1481 1498	enrolled subjects
T23	Intervention 1589 1664	eradicated by the tinidazole, tetracycline, bismuth and rabeprazole therapy
T24	Intervention 1683 1700	quadruple therapy
T25	Intervention 1800 1825	first-line triple therapy
T26	Intervention 1874 1919	triple rabeprazole-based eradicating regimens
T27	Intervention 2005 2024	three-drug regimens
T28	Intervention 2031 2048	Quadruple therapy
T29	Intervention 2087 2106	second line therapy
T30	Intervention 2193 2213	first-line treatment
